8-K - Moleculin Biotech, Inc. (0001659617) (Filer)
Moleculin Biotech, Inc.（CIK 0001659617）于 2026-10-30 向 SEC 提交 8-K，报告日期为 2026-10-30，文件含 14 份文档，涉及 Item 7.01 Regulation FD Disclosure 与 Item 9.01 Financial Statements and Exhibits。
报错 · 内容有误？请告诉我们。
Filing Date
2026-10-30
Accepted
2026-10-30 08:50:12
Documents
14
Period of Report
2026-10-30
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)
EIN.: 474671997 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 261504592
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)
来源：SEC EDGAR 8-K · sec.gov